AlzChem Group AG (ACT) Q1 2026 Earnings Report
CH:ACT Q1 2026 EPS Results
- Actual EPS
- CHF 1.63
- Consensus EPS
- CHF 1.63
- Beat/Miss
- Met expectations
- One Year Ago EPS
- CHF 1.33
CH:ACT Q1 2026 Revenue Results
- Actual Revenue
- CHF 136.95M
- Expected Revenue
- CHF 136.95M
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- +2.75%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 04/30/2026
- Time
- Before Open
- Conference Call
- Thursday, April 30, 2026
CH:ACT Upcoming Earnings
AlzChem Group AG's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q1 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:ACT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | ―- | 1.53 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 1.321.23 | 1.48 | -16.77% (-0.25) | |
| Jul 30, 2026 | 2026 (Q2) | 1.531.53 | 1.45 | 5.73% (+0.08) | |
| Apr 30, 2026 | 2026 (Q1) | 1.631.63 | 1.33 | 22.92% (+0.30) | |
| Feb 27, 2026 | 2025 (Q4) | 1.531.53 | 1.37 | 11.41% (+0.16) | |
| Oct 30, 2025 | 2025 (Q3) | 1.461.48 | 1.12 | 31.97% (+0.36) | |
| Jul 30, 2025 | 2025 (Q2) | 1.451.45 | 1.3 | 11.35% (+0.15) | |
| Apr 30, 2025 | 2025 (Q1) | ―1.33 | 1.11 | 20.00% (+0.22) | |
| Feb 28, 2025 | 2024 (Q4) | 1.081.37 | 1 | 37.33% (+0.37) | |
| Nov 07, 2024 | 2024 (Q3) | 1.12- | 0.78 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
